RecallDepth
Class II Ongoing

Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles (NDC 0378-6325-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.

This recall is currently active, issued December 19, 2018. It was issued by Mylan Laboratories Limited, (Nashik Fdf).

Company
Mylan Laboratories Limited, (Nashik Fdf)
Recall Initiated
December 4, 2018
Posted
December 19, 2018
Recall Number
D-0332-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
32,284 HDPE bottles
Firm Location
Sinnar, Nashik District, India
Official Source
View on FDA website ↗

Reason for Recall

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Distribution

Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Lot / Code Info

Lot numbers: 3084860 3084861 3084862 3093804 3084862 3084863

Other recent Class II Drug recalls